MINORITY INSTITUTIONS RESEARCH DEVELOPMENT PROGRAM NIH GUIDE, Volume 23, Number 32, August 26, 1994 P.T. 34, FF Keywords: Biomedical Research, Multidiscipl National Institute on Drug Abuse PURPOSE The purpose of this notice is to inform the research community that the National Institute on Drug Abuse (NIDA) will accept competing continuation (renewal) applications for participation in the Minority Institutions Research Development Program (MIRDP). The MIRDP was designed to increase the capacity of predominantly minority institutions and their faculty to conduct alcohol, drug abuse, and mental health research. NIDA is accepting renewal applications specific to drug abuse research. APPLICATION PROCEDURES Renewal applications are to be submitted on the grant application form PHS 398 (rev. 9/91), with a cover letter indicating the request for renewal. The application face page must also indicate across top margin "RENEWAL APPLICATION" and must be sent to: Division of Research Grants National Institutes of Health Westwood Building, Room 240 Bethesda, MD 20892** Renewals must be received in accordance with the standard receipt dates for competing continuation (renewal) applications (i.e., March 1, July 1, and November 1). Competing continuation (renewal) applications must include a progress report containing the following information: 1. Summary of institution's research projects developed or expanded through the MIRDP award; 2. Outline of drug abuse-related research development activities by institution, faculty and staff; 3. Demonstration of increased involvement or interest by minority students in drug-related research projects or pursuing drug-related research careers through participation in MIRDP-sponsored activities; 4. Review of any infrastructure enhancements to institution, including faculty ability to conduct drug abuse-related research. Include any examples of laboratory improvement, faculty development, data and statistical analysis capability, resource development, and the like. The competing continuation (renewal) application should, as in the original: (1) assess the current institutional and faculty capacity to conduct drug-related research, (2) identify unmet needs, and (3) describe the activities to further develop the institutional infrastructure and faculty capacity to conduct drug research. The continuation application should include both an institutional research development program and one or more individual investigator projects. The applicant must submit a budget detailing the costs associated with the proposed renewal, including personnel (percent effort, rate, and fringe benefits), supplies and equipment, shipping and handling expenses, laboratory costs, and expenses for study subjects including travel reimbursements, if applicable. The NIH peer review process will be used. A NIDA study section with expertise in the subject area will evaluate the scientific merit of the application, using evaluation criteria described in the MIRDP program announcement dated April 1989. INQUIRIES Questions regarding programmatic aspects and matters pertaining to the review of the application may be directed to: Lula A. Beatty, Ph.D. Special Populations Office National Institute on Drug Abuse 5600 Fishers Lane Parklawn Building, Room 10A08 Rockville, MD 20857 Telephone: (301) 443-0441 Questions regarding administrative or budgetary issues may be directed to: Gary Fleming Grants Management Branch National Institute on Drug Abuse 5600 Fishers Lane Parklawn Building, Room 8A54 Rockville, MD 20857 Telephone: (301) 443-6710 .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |